Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Journal of Neurochemistry
|
June 30, 2006
A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes
Izumi Maezawa, Hyun-Seok Hong, Hui-Chuan Wu, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study
Sandeep Rana, Elizabeth C Blowers, Calvin Tebbe, et al.
Neurobiology of Aging
|
November 22, 2008
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents
Hyun-Seok Hong, Izumi Maezawa, Madhu Budamagunta, et al.
ACS Chemical Biology
|
April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy
Jacob I Contreras, Caroline M Robb, Hannah M King, et al.
Hemato
|
October 25, 2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Alexandria P Eiken, Elizabeth Schmitz, Erin M Drengler, et al.
The Journal of Biological Chemistry
|
April 4, 2022
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
Smit Kour, Sandeep Rana, Sydney P Kubica, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2021
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
Hannah M King, Sandeep Rana, Sydney P Kubica, et al.
European Journal of Medicinal Chemistry
|
June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Satish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Bioorganic Chemistry
|
March 23, 2020
Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy
Farheen Shamsi, Phool Hasan, Aarfa Queen, et al.
Molecular Pharmacology
|
August 31, 2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
Smit Kour, Sandeep Rana, Jacob I Contreras, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Journal of Neurochemistry
|
June 30, 2006
A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes
Izumi Maezawa, Hyun-Seok Hong, Hui-Chuan Wu, et al.
Journal of Medicinal Chemistry
|
April 15, 2016
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study
Sandeep Rana, Elizabeth C Blowers, Calvin Tebbe, et al.
Neurobiology of Aging
|
November 22, 2008
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents
Hyun-Seok Hong, Izumi Maezawa, Madhu Budamagunta, et al.
ACS Chemical Biology
|
April 3, 2018
Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy
Jacob I Contreras, Caroline M Robb, Hannah M King, et al.
Hemato
|
October 25, 2024
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Alexandria P Eiken, Elizabeth Schmitz, Erin M Drengler, et al.
The Journal of Biological Chemistry
|
April 4, 2022
Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells
Smit Kour, Sandeep Rana, Sydney P Kubica, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 25, 2021
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
Hannah M King, Sandeep Rana, Sydney P Kubica, et al.
European Journal of Medicinal Chemistry
|
June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy
Satish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Bioorganic Chemistry
|
March 23, 2020
Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy
Farheen Shamsi, Phool Hasan, Aarfa Queen, et al.
Molecular Pharmacology
|
August 31, 2019
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
Smit Kour, Sandeep Rana, Jacob I Contreras, et al.
Page
of 8